14.51
price up icon1.33%   0.19
after-market Dopo l'orario di chiusura: 14.81 0.30 +2.07%
loading

Biohaven Ltd Borsa (BHVN) Ultime notizie

pulisher
Jul 27, 2026

How Biohaven’s (BHVN) Trade Secret Verdict Shapes Its Intellectual Property Defense Strategy - simplywall.st

Jul 27, 2026
pulisher
Jul 27, 2026

Federal jury awards Yale University, Biohaven $4M in trade secret suit - Westfair Communications

Jul 27, 2026
pulisher
Jul 27, 2026

Yale, Biohaven Win $4M In Biotech Trade Secret Trial - Law360

Jul 27, 2026
pulisher
Jul 27, 2026

Yale, Biohaven Win $4 Million Verdict Over Drug-Development Tech - Bloomberg Law News

Jul 27, 2026
pulisher
Jul 27, 2026

Federal jury awards Yale, Biohaven $4M in lawsuit over trade secrets - Hartford Business Journal

Jul 27, 2026
pulisher
Jul 27, 2026

Biohaven and Yale win $4M verdict in trade secret case - Investing.com Canada

Jul 27, 2026
pulisher
Jul 27, 2026

Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million - PR Newswire

Jul 27, 2026
pulisher
Jul 27, 2026

Biohaven Ltd (BHVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Biohaven Ltd (BHVN) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Biohaven Ltd (BHVN) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Biohaven Ltd (BHVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

BHVN|Biohaven Ltd|Price:14.320|Chg%:-0.320 - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

BHVN|Biohaven Ltd|Price:14.563|Chg%:+0.243 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Biohaven Ltd (BHVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

Biohaven Ltd. Revenue Breakdown – NYSE:BHVN - TradingView

Jul 25, 2026
pulisher
Jul 21, 2026

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 53% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Jul 21, 2026
pulisher
Jul 20, 2026

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits

Jul 20, 2026
pulisher
Jul 20, 2026

Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload - Finansavisen

Jul 20, 2026
pulisher
Jul 18, 2026

How Biohaven’s (BHVN) R&D Leadership Shuffle Will Impact Investors - simplywall.st

Jul 18, 2026
pulisher
Jul 17, 2026

Biohaven Ltd. (NYSE: BHVN) legal chief discloses holdings - Stock Titan

Jul 17, 2026
pulisher
Jul 17, 2026

Lobbying Update: $120,000 of BIOHAVEN LTD. lobbying was just disclosed - Quiver Quantitative

Jul 17, 2026
pulisher
Jul 17, 2026

Biohaven files Form 3 for Chief Legal Officer Warren Karl Volles - Bitget

Jul 17, 2026
pulisher
Jul 17, 2026

Price to book forward of Biohaven Ltd. – NYSE:BHVN - TradingView

Jul 17, 2026
pulisher
Jul 17, 2026

Discipline and Rules-Based Execution in BHVN Response - Stock Traders Daily

Jul 17, 2026
pulisher
Jul 17, 2026

Biohaven (BHVN) 10K Form and Latest SEC Filings 2026 - MarketBeat

Jul 17, 2026
pulisher
Jul 14, 2026

Price to earnings forward of Biohaven Ltd. – BOATS:BHVN - TradingView

Jul 14, 2026
pulisher
Jul 13, 2026

Biohaven Research Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.33333333 Shs - TradingView

Jul 13, 2026
pulisher
Jul 13, 2026

Biohaven: Nice Pipeline Momentum, But Its Runway Is A Risk (NYSE:BHVN) - Seeking Alpha

Jul 13, 2026
pulisher
Jul 12, 2026

Enterprise value to EBIT forward of Biohaven Ltd. – BOATS:BHVN - TradingView

Jul 12, 2026
pulisher
Jul 12, 2026

Price to sales forward of Biohaven Ltd. – NYSE:BHVN - TradingView

Jul 12, 2026
pulisher
Jul 12, 2026

Price to sales forward of Biohaven Ltd. – BOATS:BHVN - TradingView

Jul 12, 2026
pulisher
Jul 11, 2026

Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Co - GuruFocus

Jul 11, 2026
pulisher
Jul 11, 2026

Biohaven (BHVN) Advances Key Trials Following Pipeline Progress While Valuation Still Looks Pricey - Sahm

Jul 11, 2026
pulisher
Jul 10, 2026

Enterprise value to revenue forward of Biohaven Ltd. – NYSE:BHVN - TradingView

Jul 10, 2026
pulisher
Jul 10, 2026

BHVN News | BIOHAVEN LTD (NYSE:BHVN) - ChartMill

Jul 10, 2026
pulisher
Jul 10, 2026

Biohaven announces leadership changes - Hartford Business Journal

Jul 10, 2026
pulisher
Jul 10, 2026

Biohaven Announces Scientific Leadership Changes - Contract Pharma

Jul 10, 2026
pulisher
Jul 10, 2026

ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership - Yahoo Finance

Jul 10, 2026
pulisher
Jul 10, 2026

Is Biohaven’s (BHVN) R&D Shake-Up Quietly Redefining Its Late-Stage Pipeline Strategy? - Yahoo Finance

Jul 10, 2026
pulisher
Jul 09, 2026

Biohaven Announces Scientific Leadership Transitions - GuruFocus

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven Chief Scientific Officer Bruce Car to Transition to Chief Innovation Officer - Moomoo

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven: Bruce Car, Transitioning From Chief Scientific Officer to Chief Innovation Officer Focusing on External Collaborations >BHVN - Moomoo

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven Announces Leadership Changes to Accelerate CNS Drug Discovery and Innovation Through Bexorg Collaboration – Minichart - Minichart

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven announces leadership changes in discovery unit By Investing.com - Investing.com India

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven announces leadership changes in discovery unit - Investing.com

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven (NYSE: BHVN) shifts CSO to innovation role, promotes discovery head - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Biohaven (BHVN) Completes Enrollment in RISE3 Trial - Yahoo Finance

Jul 09, 2026
pulisher
Jul 08, 2026

BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts - Yahoo Finance

Jul 08, 2026
pulisher
Jul 08, 2026

Janus Henderson holds 8.58M Biohaven shares (BHVN) — 5.7% stake - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Biohaven (BHVN) Is Up 5.6% After Advancing Two Late-Stage Trials in Epilepsy and Graves’ Disease - simplywall.st

Jul 08, 2026
pulisher
Jul 07, 2026

10 Best Performing American Stocks in June 2026 - Insider Monkey

Jul 07, 2026
pulisher
Jul 06, 2026

Why Wall Street Is Growing More Cautious on Biohaven (BHVN) - Insider Monkey

Jul 06, 2026
pulisher
Jul 05, 2026

BHVNBiohaven Ltd Latest SEC Filings - Finviz

Jul 05, 2026
pulisher
Jul 03, 2026

Biohaven Shares Drop 9.8% to $14.28 - Intellectia AI

Jul 03, 2026
pulisher
Jul 02, 2026

Biohaven (BHVN) Insider Trading Activity 2026 - MarketBeat

Jul 02, 2026
pulisher
Jul 01, 2026

Does Advancing Opakalim and BHV-1300 to Pivotal Trials Change The Bull Case For Biohaven (BHVN)? - simplywall.st

Jul 01, 2026
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
Capitalizzazione:     |  Volume (24 ore):